Regencell bioscience holdings limitedRGC.US Overview

US StockHealthcare

(No presentation for RGC)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

RGC Overall Performance

RGC AI Analysis & Strategy

RGC Recent Performance

1.66%

Regencell bioscience holdings limited

0.81%

Avg of Sector

-1.14%

S&P500

RGC PowerScanner

RGC Key Information

RGC Valuation Metrics

RGC Earnings Table

RGC Profile

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.